BIANCHI, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 22.290
EU - Europa 13.239
AS - Asia 13.018
SA - Sud America 2.093
AF - Africa 326
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 12
Totale 51.005
Nazione #
US - Stati Uniti d'America 21.837
FI - Finlandia 6.102
SG - Singapore 4.849
CN - Cina 3.544
BR - Brasile 1.654
IT - Italia 1.449
VN - Vietnam 1.363
DE - Germania 1.345
UA - Ucraina 1.071
HK - Hong Kong 1.018
PL - Polonia 922
TR - Turchia 702
GB - Regno Unito 672
FR - Francia 428
SE - Svezia 403
JP - Giappone 340
RU - Federazione Russa 316
IN - India 278
CA - Canada 202
MX - Messico 198
AR - Argentina 171
BD - Bangladesh 171
ID - Indonesia 167
NL - Olanda 142
ZA - Sudafrica 121
IQ - Iraq 97
ES - Italia 81
CO - Colombia 72
PK - Pakistan 70
BE - Belgio 67
EC - Ecuador 60
LT - Lituania 47
MA - Marocco 46
IR - Iran 45
PH - Filippine 43
UZ - Uzbekistan 43
AT - Austria 42
VE - Venezuela 42
CL - Cile 35
MY - Malesia 35
SA - Arabia Saudita 35
EG - Egitto 34
PY - Paraguay 29
CZ - Repubblica Ceca 27
KE - Kenya 26
TN - Tunisia 26
AE - Emirati Arabi Uniti 25
AU - Australia 25
JO - Giordania 20
KR - Corea 19
NP - Nepal 17
CH - Svizzera 16
DZ - Algeria 14
RO - Romania 14
AZ - Azerbaigian 13
IL - Israele 13
ET - Etiopia 12
GR - Grecia 12
PS - Palestinian Territory 12
TH - Thailandia 12
IE - Irlanda 11
PE - Perù 11
PT - Portogallo 11
BO - Bolivia 10
LB - Libano 10
TW - Taiwan 10
JM - Giamaica 9
KW - Kuwait 9
KZ - Kazakistan 9
NG - Nigeria 9
AL - Albania 8
CR - Costa Rica 8
LV - Lettonia 8
PA - Panama 8
BH - Bahrain 7
OM - Oman 7
DO - Repubblica Dominicana 6
EU - Europa 6
GA - Gabon 6
KG - Kirghizistan 6
MD - Moldavia 6
NI - Nicaragua 6
RS - Serbia 6
UY - Uruguay 6
GE - Georgia 5
LY - Libia 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
CI - Costa d'Avorio 4
HU - Ungheria 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CG - Congo 3
EE - Estonia 3
MT - Malta 3
NO - Norvegia 3
QA - Qatar 3
SI - Slovenia 3
SR - Suriname 3
TT - Trinidad e Tobago 3
YE - Yemen 3
Totale 50.942
Città #
Helsinki 5.750
Singapore 3.049
Ashburn 2.675
Woodbridge 1.918
Fairfield 1.705
San Jose 1.276
Beijing 1.264
Chandler 1.186
Jacksonville 1.180
Houston 1.138
Ann Arbor 1.107
Hong Kong 998
Santa Clara 920
Warsaw 893
Seattle 694
Wilmington 672
Cambridge 572
New York 446
Ho Chi Minh City 444
Dallas 431
Nanjing 395
Izmir 384
Ferrara 370
Hanoi 351
Munich 349
Los Angeles 340
Tokyo 316
Princeton 277
Lauterbourg 243
Boardman 201
Council Bluffs 193
Bremen 172
Shanghai 154
Milan 150
São Paulo 148
San Diego 142
Bologna 119
Shenyang 117
Mexico City 115
Orem 113
Turku 105
Nanchang 102
Jakarta 101
Addison 98
London 91
Tianjin 79
Hefei 76
Hebei 75
Frankfurt am Main 73
Chicago 70
Changsha 67
Chennai 67
Johannesburg 66
Brussels 63
Redwood City 63
Denver 62
Montreal 62
Stockholm 61
Brooklyn 60
Buffalo 60
Falls Church 59
Rio de Janeiro 59
Falkenstein 57
Haiphong 57
Da Nang 56
Jiaxing 56
Toronto 56
The Dalles 55
Atlanta 54
Moscow 54
Mountain View 48
San Francisco 47
Jinan 45
Amsterdam 44
Poplar 43
Zhengzhou 43
Phoenix 42
Dearborn 41
Guangzhou 41
Ningbo 39
Belo Horizonte 37
Dhaka 35
Baghdad 34
Tashkent 34
Manchester 33
Mumbai 33
San Mateo 33
Boston 32
Norwalk 32
Dong Ket 30
Rome 29
Auburn Hills 28
Des Moines 27
Brasília 26
Nuremberg 26
Vienna 26
Columbus 25
Curitiba 25
Ankara 24
Düsseldorf 24
Totale 36.057
Nome #
Use of angelicin and of its structural analogues for the treatment of thalassemia 1.973
SYNTHETIC OLIGONUCLEOTIDES AS INDUCERS OF ERYTHROID DIFFERENTIATION 1.966
Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale Distamicina A 1.961
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 523
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 413
A validated cellular biobank for β-thalassemia 411
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 375
Pyrazolo-triazoles as light activable dna cleaving agents 369
A validated THALAMOSS cellular biobank for β-thalassemia 329
Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports 299
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 295
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 294
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 289
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 271
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 270
Drug repurposing and transposable elements: a new promising strategy to fight prostate cancer 265
Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition 253
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 252
Alteration of the expression of human estrogen receptor gene by distamycin 245
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 241
Possible detection of Autologous Blood Transfusion (ABT) based on circulating plasma microRNAs involved in erythroid differentiation and fetal hemoglobin induction 240
Alternate PNA-DNA chimeras (PNA-DNA)(n): synthesis, binding properties and biological activity 239
Analytic and dynamic secretory profile of patient-derived cytokine-Induced killer cells 234
A chromatographic procedure for fully automated isolation of DNA from human whole blood 233
Cellular Uptakes, Biostabilities and Anti-miR-210 Activities of Chiral Arginine-PNAs in Leukaemic K562 Cells 233
A non-radioactive automated protocol to study protein-DNA interactions by DNase I footprinting 232
High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222 232
Altered erythroid-related miRNA levels as a possible novel biomarker for detection of autologous blood transfusion misuse in sport 231
Analysis of the human HLA-DRA gene upstream region: evidence for a stem-loop array directed by nuclear factors 230
Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines 228
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 225
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 225
Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA 224
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 220
A liquid biopsy model: Circulating miRNA levels in mice bearing colorectal carcinoma tumor xenografts 220
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 219
Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum 218
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 217
Induction of apoptosis of human glioma cell lines: Effects of combined treatment with corilagin and temozolomide 216
Targeting Transcription Factor Activity as a Strategy to Inhibit Pro-Inflammatory Genes Involved in Cystic Fibrosis: Decoy Oligonucleotides and Low-Molecular Weight Compounds 215
Spotlight on the transglutaminase 2 gene: A focus on genomic and transcriptional aspects 214
Biosensor technology and surface plasmon resonance for real-time detection of genetically modified Roundup Ready soybean gene sequences 212
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 212
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 211
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 210
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 210
The biocompatibility of materials used in printed circuit board technologies with respect to primary neuronal and K562 cells 209
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 208
Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen 206
Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells 206
Somatic and germline variants affect prognosis and susceptibility in prostate cancer 203
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 203
Analysis of Differential Expression of TG2 Variants During Treatment with Retinoic Acid Highlights a New 3'-Terminal Transcript and Putatively Involved Proteins 203
Regulation of IL-8 gene expression in gliomas by microRNAs 202
Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin 202
A NOVEL USE OF RAPAMYCN AND STRUCTURAL ANALOGUES THEREOF 202
Structure and Biological Activity of Furocoumarins 200
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants 200
Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites 199
RNA analysis indicates tight correlation between the expression of a long non coding RNA and the TG2 mRNA levels 199
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 199
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 198
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 198
Liposomes as carriers for DNA-PNA hybrids 193
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 193
Binding of distamycin and chromomycin to human immunodeficiency type 1 virus DNA: a non-radioactive automated footprinting study 192
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 191
Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer 191
Loss of heterozygosity in ovarian cancer: detection by PCR and microsatellite polymorphism. 190
Polymerase-chain reaction as a tool for investigations on sequence-selectivity of DNA-drugs interactions 188
Differential expression of A3 adenosine receptors in colorectal cancer and related mucosa: a mirror in blood cells. 187
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 187
Sequencing of an upstream region of the human HLA-DRA gene containing X' and Y' boxes 187
Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression 187
Plants with antitumor properties:from biologically active molecules to drugs 186
Inhibition of miRNA Maturation by Peptide Nucleic Acids. 186
Induction of erythroid differentiation of human K562 cells by cisplatin analogs 186
Capillary electrophoresis: detection of hybridization between synthetic oligonucleotides and HIV-1 genomic DNA amplified by polymerase-chain reaction 185
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 185
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 185
Alteration of microRNA biological activity with peptide nucleic acid 184
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites 183
Sequencing of an RNA transcript of the human estrogen receptor gene: evidence for a new transcriptional event. 183
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 183
Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA 183
Biosensor technology and surface plasmon resonance for real-time detection of HIV-1 genomic sequences amplified by polymerase chain reaction 183
New trends in non-invasive prenatal diagnosis: Applications of dielectrophoresis-based Lab-on-a-chip platforms to the identification and manipulation of rare cells (Review) 182
Cellular biosensors for the identification of fetal hemoglobin inducers 182
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 182
In vitro and in vive binding of a CC-1065 analogue to human gene sequences: A polymerase-chain reaction study 179
Gene Modulation by Peptide Nucleic Acids (PNAs) Targeting microRNAs (miRs) 179
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 179
Effects of Medicinal Plant Extracts on Molecular Interactions between DNA and Transcription Factors 178
Surface plasmon resonance for real-time monitoring of molecular interactions between a triple helix forming oligonucleotide and the Sp1 binding sites of human Ha-ras promoter: effects of the DNA-binding drug chromomycin 178
Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites 178
Polymerase-chain reaction: analysis of DNA/DNA hybridization by capillary electrophoresis 177
Differential effects of distamycin analogues on amplification of human gene sequences by polymerase-chain reaction 177
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 176
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 176
Biospecific interaction analysis (BIA) of low-molecular weight DNA- binding drugs 174
Totale 27.326
Categoria #
all - tutte 198.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.213
Totale 203.162


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.416 0 0 0 0 0 0 0 0 0 452 555 409
2021/20222.596 234 221 115 90 167 163 95 124 81 261 308 737
2022/20232.754 290 208 86 354 526 398 117 239 283 19 142 92
2023/20241.960 130 205 62 52 140 383 97 319 18 33 80 441
2024/20256.722 206 240 569 329 696 549 258 387 1.052 784 913 739
2025/202622.083 1.626 775 1.577 2.268 2.504 1.161 2.143 1.060 7.240 1.729 0 0
Totale 51.644